BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240925
DTSTAMP:20260403T124443
CREATED:20240227T171412Z
LAST-MODIFIED:20240731T191635Z
UID:1817-1727136000-1727222399@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2024
DESCRIPTION:Deal and investment activity remains critical to the success of life sciences and healthcare innovation. \nRSVP Here \n \n\n\n\n\n\n\n\nSidley once again brings together senior pharma\, biotech\, healthcare\, private equity\, and venture capital executives to share their perspectives on critical issues\, trends\, and opportunities. \nJoin Sidley and industry leaders from across the globe\, including from AstraZeneca\, BioCentury\, Compass Pathways\, Financial Times\, Flagship Pioneering\, IQVIA\, J.P. Morgan\, LetterOne Health\, Mestag Therapeutics\, Morgan Stanley\, Novartis\, Onex\, Permira\, Perspectum\, Rothschild & Co.\, Sofinnova Partners\, Syncona\, SV Health Investors\, and Teva for this in-person\, all-day event. Virtual attendance is available to those outside the UK. \nView the agenda here.\nView confirmed speakers here. \nPanels will include: \n\nPrivate Equity – What is the outlook for PE investment activity across Healthcare and Life Sciences? Which domains will be the “winners”?\n\nArtificial Intelligence – To what extent\, and where\, does AI represent an investment opportunity across Healthcare and Life Sciences?\n\nFireside Chat – “A Life in Pharma and Pivoting to Innovation”- A conversation with Richard Francis\, President and CEO\, Teva.\n\nA View From the Banks – Opinions\, insights\, and predictions on the market from a group of leading global healthcare dealmakers.\n\nPharma Business Development – Senior BD and biotech figures debate the M&A\, licensing\, and collaboration climate. Which therapeutic areas and geographies are garnering the most attention?\n\nVenture/Growth Capital – How are global funds investing in a more muted market? How do investees stand out? Views from leading global life sciences investors.\n\nPlease note\, due to space limitation for this event\, registrations will be reviewed and confirmed by email in due course. We strongly encourage in-person attendance and remote participation will be available to those based outside of the UK. \nFor more information or questions\, please contact lnevents@sidley.com. \nSIDLEY HEALTHCARE INVESTMENT CONFERENCE 2023 HIGHLIGHTS \n\nView the 2023 agenda\nSidley Healthcare Investment Conference 2023 Highlights Video\nA Life Well Invented: A Discussion Between Moderna Co-Founder and Chairman Noubar Afeyan and Sidley’s Robert Darwin
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2024/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240909
DTEND;VALUE=DATE:20240914
DTSTAMP:20260403T124443
CREATED:20240306T210249Z
LAST-MODIFIED:20240320T151628Z
UID:1835-1725840000-1726271999@goodlifesci.sidley.com
SUMMARY:Data Integrity and Governance Workshop
DESCRIPTION:Live Oak Workshops\, in collaboration with Sidley Austin\, are designed to equip you with the knowledge and critical thinking strategies that lead to success in the advancement of your GXP career. As worldwide regulatory expectations in the world of data integrity and data governance change\, our workshops prepare you with the skills necessary to interpret regulations\, guidance\, and regulatory action into simple approaches for managing your everyday GXP responsibilities with the efficiency needed to thrive. \nMonday\, September 9\, 2024 – Tuesday\, September 10\, 2024 | Ahmedabad\, India\nThursday\, September 12\, 2024 – Friday\, September 13\, 2024 | Hyderabad\, India \nSign up now to join us as we discuss\, debate\, question\, and tackle interesting regulatory case studies in the world of data integrity and data governance. \nWe are excited to now offer this worship in both Ahmedabad and Hyderabad this October. Click here to see the full two-day agenda. \nInstructors include former FDA India Office alums: \nPeter Baker\, President\, Live Oak\nFormer FDA Investigator\nPeter Baker is a GXP consultant focused on improving the quality of medicines by providing training and consulting services to organizations looking to improve the quality of their data integrity assurance strategy. Pete is a former FDA investigator whose Agency leadership included serving as Assistant Country Director (Drugs) in New Delhi\, where he performed high risk cGMP inspections of human drug manufacturers throughout India and the surrounding region\, conducted a variety of training and development exercises for manufacturers and foreign regulators\, performed joint GMP manufacturing inspections with a variety of foreign regulatory bodies\, and conducted joint investigations alongside local and regional investigation teams to facilitate harmonized regulatory actions. In 2013\, he was recognized as FDA Investigator of the year due to a significant number of FDA regulatory actions taken in India\, including product recalls and import bans based on inspections where breaches in data integrity were uncovered which affected a wide variety of products in US distribution. \nJay Jariwala\, Senior Director\, Regulatory Compliance\, Sidley\nFormer FDA Regulator\nFor over 13 years\, Jay served as an FDA regulator and leader at multiple FDA centers\, including CDER\, the Center for Devices and Radiological Health (CDRH)\, and the Office of the Commissioner\, applying the agency’s laws\, regulations\, guidance\, and other technical and administrative policies on drugs\, medical devices\, and combination products to policy development\, facility inspections\, compliance\, enforcement\, and approval processes. His FDA leadership experience includes serving as assistant country director (Drugs) and supervisory Consumer Safety officer in the agency’s India Office in New Delhi\, where he managed a team of investigators for all facility inspections conducted by the India Office and compliance follow-up. In addition to his responsibilities for resource planning and operational oversight for violative establishment inspection assessments and resulting regulatory actions\, Jay trained FDA investigators on current good manufacturing practice (CGMP) requirements — particularly data integrity and quality investigations. \nDan Roberts\, Senior Director\, Regulatory Compliance\, Sidley\nFormer FDA Investigator\nDan Roberts evaluates and assesses pharmaceutical quality systems and focuses on detecting and remediating data integrity concerns and evaluating compliant automated manufacturing processes and related computerized systems. He provides guidance and assists clients in responding to FDA-483 observations\, corresponding with regulatory agencies\, and conducting mock FDA facility audits. Dan has over 20 years of government regulatory and pharmaceutical/biopharmaceutical industry experience. He was an FDA investigator for eight years\, including two years as the primary point of contact for conducting pharmaceutical inspections at the FDA India office located at the U.S. Embassy in New Delhi. He was also the first lead investigator for the first biosimilar inspection conducted by the FDA in India. \nJim Johnson\, Partner\, Sidley\nFormer FDA Associate Chief Counsel\nJim Johnson guides life sciences companies through complex FDA compliance and enforcement matters\, including inspections\, current good manufacturing practices (GMP) requirements\, data integrity responsibilities\, product quality issues\, pharmacovigilance obligations\, and enforcement actions. Jim previously served as Associate Chief Counsel for Enforcement in the FDA’s Office of the Chief Counsel\, where he handled GMP enforcement and provided legal counsel on a range of inspectional and compliance issues to agency components\, particularly the FDA’s Office of Regulatory Affairs (ORA) and Center for Drug Evaluation and Research’s (CDER) Office of Compliance. Jim uses his extensive agency and private practice experience to assist pharmaceutical and biotechnology companies worldwide\, regularly conducting GMP assessments and investigations\, resolving warning letters and import alerts\, and appearing in front of the FDA on behalf of companies to resolve enforcement actions. \nDiscounts and Additional Information: \n\nContracts info@liveoakqa.com for groups of five or larger and receive a 10% discount code for checkout\nTea Breaks and lunch are included in the workshop.
URL:https://goodlifesci.sidley.com/event/data-integrity-and-governance-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240904
DTEND;VALUE=DATE:20240905
DTSTAMP:20260403T124443
CREATED:20240522T164830Z
LAST-MODIFIED:20240522T164830Z
UID:1944-1725408000-1725494399@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2024: Harnessing Market Dynamics for Profitability
DESCRIPTION:Join Sidley\, ISS AG\, and Swiss Medtech in Biel for an afternoon of practical tips and interactive discussions on current issues\, including: \n\nESG and its development in the EU\nSeizing the opportunities of Artificial Intelligence\nHealth data and clinical trials\n\n \n2:00 p.m. – 6:30 p.m. CET\nFollowed by a networking drinks reception \nRSVP here. \nIndustry speakers\, regulators\, scientific experts\, and counsel will share tips and best practices for the challenges and opportunities that lie ahead for Swiss MedTech. \nWHO SHOULD ATTEND?\nExecutives\, investors\, in-house counsel\, and regulatory managers interested in and/or facing regulatory issues in Switzerland. \nFor more information\, please contact Dafne Forni Zervoudaki at +32 2 504 6202 or at dafne.fornizervoudaki@sidley.com.
URL:https://goodlifesci.sidley.com/event/swiss-medtech-2024-harnessing-market-dynamics-for-profitability/
LOCATION:Farelhaus\, Oberer Quai 12\, 2503 Biel\, Switzerland\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240514T130000
DTEND;TZID=America/New_York:20240514T140000
DTSTAMP:20260403T124443
CREATED:20240502T211916Z
LAST-MODIFIED:20240502T212138Z
UID:1923-1715691600-1715695200@goodlifesci.sidley.com
SUMMARY:FDA’s New Wave of Promotion Enforcement: What You Need to Know Now
DESCRIPTION:After several years of relatively little enforcement\, FDA has recently been flexing its muscles in the promotion area. The Office of Prescription Drug Promotion (OPDP) in particular has issued several notable warning and untitled letters in the past year\, representing an increased volume in enforcement and increased scrutiny of efficacy claims. This includes more rigorous assessment of information “consistent with” FDA-required labeling (CFL) and enforcement of new expectations for presentation of quantitative efficacy information. Tune in to this overview session for an efficient rundown of what this means for drug\, biological product\, and device manufacturers in terms of key watchouts and practical approaches to risk mitigation. \nRSVP here.\n \n1:00 p.m. – 2:00 p.m. ET \nCLE credit will be offered for this webinar.\nSidley Austin LLP is an accredited MCLE provider in IL\, NY\, and CA. Credit is available for CT\, NJ\, TX\, and VA upon request.
URL:https://goodlifesci.sidley.com/event/fdas-new-wave-of-promotion-enforcement-what-you-need-to-know-now/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240507T080000
DTEND;TZID=America/Chicago:20240507T093000
DTSTAMP:20260403T124443
CREATED:20240321T150358Z
LAST-MODIFIED:20240321T150358Z
UID:1872-1715068800-1715074200@goodlifesci.sidley.com
SUMMARY:ICCA 2024 Hong Kong Sidley Breakfast Seminar
DESCRIPTION:Join us for an engaging and informative panel discussion on life sciences disputes as part of ICCA 2024 Hong Kong. Our panel comprising Sidley disputes and life sciences specialists as well as inhouse counsel will explore (i) general trends in life sciences transactions\, (ii) the complexities and unique challenges involved in life sciences disputes with a focus on IP and cross-border issues\, (iii) strategies on how to avoid and manage potential disputes in life sciences transactions\, and (iv) case studies and practical insights. \nRSVP Here \n \n8:00 a.m. HKT: Registration\n8:30 – 9:30 a.m. HKT: Panel discussion \nOur international panel of specialists will comprise partners from Sidley’s Global Arbitration\, Trade and Advocacy and Global Life Sciences practices\, as well as representatives from the life sciences industry.
URL:https://goodlifesci.sidley.com/event/icca-2024-hong-kong-sidley-breakfast-seminar/
LOCATION:The Clipper\, The American Club\, Floors 48-49\, Two Exchange Square\, Central\, Hong Kong
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240501
DTEND;VALUE=DATE:20240502
DTSTAMP:20260403T124443
CREATED:20240416T162301Z
LAST-MODIFIED:20241118T220313Z
UID:1910-1714521600-1714607999@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Join Sidley at our annual Boston Life Sciences Roundtable for an afternoon of engaging discussion addressing cutting-edge trends and hot topics. \n \n1:30 p.m. Registration | 2:00 p.m. Program | 5:00 p.m. Reception\nFor more information\, contact bosevents@sidley.com. \nFEATURED PANEL TOPICS\n\nI Used To Practice Law: A Conversation with Life Sciences Leaders\nA rare few life sciences leaders have served in both chief legal and chief business officer roles during the course of their careers.  Join our discussion of making the transition  \n\n\n\nAnna Barry\, Venture Partner\, Deerfield Management\nJerald Korn\, Chief Executive Officer\, Ropirio Therapeutics\, Inc.\nAsher Rubin\, Partner\, Global Co-leader\, Technology and Life Sciences Transactions\nBecky Wood\, Partner\, Global Co-leader\, Food\, Drug and Medical Device and former FDA Chief Counsel\n\n\n\nStrategies for Success: Navigating Current Healthcare and FDA Trends for Life Sciences Companies\nThe session will cover hot topics and regulatory developments from both an FDA and healthcare perspective. \n\n\n\nScott Kaplan\, Deputy General Counsel\, Baxter International Inc.\nPeter Smith\, Head of Legal\, argenx US\, Inc.\nDonielle McCutcheon\, Partner\, Healthcare\nJim Johnson\, Partner\, Food\, Drug and Medical Device\n\n\n\nLife Sciences Transactions: Updates and Perspectives on the Market\nFrom green shoots and increased deal activity to supply chain disruptions and Congressional investigations\, this panel will explore important updates affecting the environment for life sciences transactions. \n\n\n\nAndy Meyerson\, Managing Director\, Locust Walk\n\nJason Russell\, Managing Director\, Global Head of Biotechnology\, Morgan Stanley\nMichael Borden\, Partner\, Leader\, Government Strategies\nAlison Lehner\, Partner\, Emerging Companies and Venture Capital\nAdriana Tibbitts\, Partner\, Technology and Life Sciences Transactions
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-3/
LOCATION:MassBio Hub\, 700 Technology Square\, Cambridge\, MA 02139
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/06/MN14393-Boston-Life-Sciences-Event-Banner-865px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230912T113000
DTEND;TZID=Europe/London:20230912T183000
DTSTAMP:20260403T124443
CREATED:20230622T142746Z
LAST-MODIFIED:20230622T142851Z
UID:1648-1694518200-1694543400@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2023
DESCRIPTION:With deal and investment activity remaining critical for the success of the life sciences and healthcare industry\, Sidley is bringing together senior pharma\, biotech\, healthcare\, private equity\, and venture capital leads to provide their insights on key topics\, trends\, and opportunities. \nRSVP Here \nJoin Sidley and industry leaders from across the globe for this in-person\, one-day event in London\, with the option to stream and network virtually from outside the UK. \nWe look forward to incisive content\, robust discussion\, and valuable networking during a day looking at the continued combination of innovation and capital driving positive patient outcomes and investment returns. \nView confirmed speakers. \nView agenda.\n\nPlease note\, due to space limitation for this event\, registrations will be reviewed and confirmed by email in due course. We strongly encourage in-person attendance and remote participation will be available to those based outside of the UK. \nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow applicable guidelines. \nFor more information or questions\, please contact lnevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2023/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20230628T130000
DTEND;TZID=America/Chicago:20230628T163000
DTSTAMP:20260403T124443
CREATED:20230517T203419Z
LAST-MODIFIED:20230620T212823Z
UID:1573-1687957200-1687969800@goodlifesci.sidley.com
SUMMARY:Bay Area Lifesciences Roundtable
DESCRIPTION:Please join Sidley for the Bay Area Lifesciences Roundtable\, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. \n \nFeatured Panels \nGetting Approved: Creative Approaches to Ensuring Regulatory Success in New Product Development \n\nLisa Taylor Ash\, General Counsel\, Shape Therapeutics\nMaryam Khotani\, Associate General Counsel\, Practice Group Leader\, Genentech\nMichael Listgarten\, General Counsel\, RAPT Therapeutics\nJoel Silver\, JD\, RAC\, Lead Regulatory Counsel at Gilead Sciences\nTorrey Cope\, Partner\, Food\, Drug and Medical Device\, Sidley\n\nGetting Paid: Strategies to address emerging issues in drug pricing and reimbursement at all phases of drug development\, marketing\, and business development activities. \n\nMegan Duplanty\, Vice President\, Deputy General Counsel\, BioMarin Pharmaceutical Inc.\nErin Quirk\, M.D.\, President\, Terns Pharmaceuticals\nRekha Ramesh\, Vice President\, Head of Global Policy\, Government Affairs and Policy\, Gilead Sciences\nMeenakshi Datta\, Partner\, Global Co-leader\, Healthcare\, Sidley\n\nGetting Funded: Prioritizing your pipeline and exploring funding alternatives and strategic opportunities to advance your initiatives. \n\nRekha Hemrajani\, Member\, Board of Directors\, BioAge Labs\nGrace McMahon\, Head of Transactions\, Merck\nFrank Tang\, Executive Director\, Morgan Stanley\nFrank Rahmani\, Partner\, Global Life Sciences and Capital Markets\, Sidley\n\nAgenda \n1:00 p.m. – Registration\n1:30 p.m. – Program\nCocktail reception to follow \nWho Should Attend \nExecutives\, Investors\, General Counsel and Company Counsel \nFor questions\, please contact GlobalLifeSci@sidley.com.
URL:https://goodlifesci.sidley.com/event/bay-area-lifesciences-roundtable/
LOCATION:SFMOMA Outdoor Sculpture Garden\, 147 Minna St.\, Floor 5\, San Francisco\, CA\, 94105\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230605
DTEND;VALUE=DATE:20230606
DTSTAMP:20260403T124443
CREATED:20230524T191817Z
LAST-MODIFIED:20230524T191817Z
UID:1601-1685923200-1686009599@goodlifesci.sidley.com
SUMMARY:Sidley Networking Reception at BIO
DESCRIPTION:Please join Sidley for a networking event during BIO 2023. Connect with fellow biotech and pharma colleagues and engage in discussion about industry trends and learnings from BIO. \nRSVP Here\nPlease RSVP by Friday\, May 26. \n \nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow current CDC guidelines.
URL:https://goodlifesci.sidley.com/event/sidley-networking-reception-at-bio/
LOCATION:Legal Sea Foods – Harborside\, 3rd Floor East Deck 270 Northern Avenue\, A 10 minute walk / 3 minute drive from the Boston Convention and Exhibition Center\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230523
DTEND;VALUE=DATE:20230524
DTSTAMP:20260403T124443
CREATED:20230215T183630Z
LAST-MODIFIED:20230215T185738Z
UID:1455-1684800000-1684886399@goodlifesci.sidley.com
SUMMARY:The EU’s New Health Technology Assessments Regulation
DESCRIPTION:Join us in Brussels for our next Women’s Life Sciences Network event\, which will feature a special address by Ruta Janeckaite (European Commission). \n \nThe discussion will include: \n\nStatus of the Commission’s preparation and tasks ahead\nRegulatory opportunities\nIndustry implementation path\n\nA Q&A session will follow the moderated discussion. \n6:00 p.m. CET \nThe panel discussion will be followed by networking drinks \nDr. Ruta Janeckaite\, PhD\nLegal Officer\nEuropean Commission \nRuta is a Lithuanian lawyer\, graduate from the Law Faculty of Vilnius University. Since 2003\, she has been working in the field of EU and EEA law: in the European Law Department under the Ministry of Justice of Lithuania from 2003 to 2013\, in the EFTA Surveillance Authority from 2013 to 2020\, and in the European Commission since 2020. Currently\, she is part of DG SANTE health technology assessment team\, responsible for legal issues relating to the implementation and application of Regulation (EU) 2021/2282 on health technology assessment. \nIn January 2022\, Ms. Janeckaite was accorded a doctor’s degree by Vilnius University\, for the dissertation\, “The impact of the EU internal market freedoms and competition rules on the organisation and regulation of the Lithuanian system of health protection.” \nFor more information\, please contact Cristina Menendez Ruiz at +32 2 504 6453 or at cmenendezruiz@sidley.com.\n\nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow applicable guidelines.
URL:https://goodlifesci.sidley.com/event/the-eus-new-health-technology-assessments-regulation/
LOCATION:Comet\, Place Stephanie 50\, Brussels\, 1050\, Belgium
ATTACH;FMTTYPE=image/png:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/10/MN-11337-WLSN-Sidley-865px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230511
DTEND;VALUE=DATE:20230512
DTSTAMP:20260403T124443
CREATED:20230404T175257Z
LAST-MODIFIED:20241118T220253Z
UID:1527-1683763200-1683849599@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Please join Sidley for the Boston Life Sciences Roundtable\, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. \n \n \nFEATURED PANELS \n Please see below for discussion topics during the Boston Life Sciences Roundtable: \nLeading Life Sciences Companies: A Conversation with Boston Area Life Sciences General Counsel\n \n\nTy Howton\, Chief Administrative Officer and Secretary\, Solid Biosciences Inc.\nJoan Schmidt\, Chief Legal Officer\, Pharvaris\nAsher Rubin\, Partner\, Co-leader\, Technology and Life Sciences Transactions\nBecky Wood\, Partner\, Co-leader\, Food\, Drug and Medical Device and former FDA Chief Counsel\n\nCharting New Courses: Key Healthcare and FDA Developments for Life Sciences Companies\n \n\nJoe Philipose\, Chief Ethics and Compliance Officer\, Emergent BioSolutions\nLynn Zuchowski\, Vice President\, Chief Counsel\, Severe Genetic Diseases\, bluebird bio\, Inc.\nMeena Datta\, Partner\, Co-leader\, Healthcare\nScott Kaplan\, Partner\, Food\, Drug and Medical Device\n\nProspecting in Uncertain Times: New Approaches to Funding the Next Blockbuster\n \n\nSusan Graf\, Senior Advisor & Entrepreneur In Residence\, Locust Walk; Board Chair\, Finch Therapeutics; Audit Committee Chair\, Kaléo\nMike Mano\, Senior Vice President and General Counsel\, Karyopharm Therapeutics\nGeoff Levin\, Partner\, Private Equity\nAlison Lehner\, Partner\, Emerging Companies and Venture Capital\n\nKeynote Presentation \n\nLeading With Empathy: Understanding Compassion and Emotional Storytelling for Life Sciences Companies\n\nYotam Dagan\nA former Israeli Navy SEALs commander\, certified clinical psychologist\, and hostage negotiator\, Yotam has moved from leading soldiers on the battlefield to building their fighting capacity and caring for their wellbeing. A global resilience expert\, Yotam founded Dugri Inc – a startup that builds real-talk-based\, safe\, vertical communities. His book\, A Time to Kill\, a Time to Heal – An Israeli Navy SEAL’s Journey\, came out in 2021. \nAGENDA \n1:30 p.m. Arrival and Registration\n2:00 p.m. Program\n5:30 p.m. Reception \nJoin us on-site during the reception for a special hands-on service project.
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-2/
LOCATION:MassBio Hub\, 700 Technology Square\, Cambridge\, MA 02139
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230510T140000
DTEND;TZID=America/New_York:20230510T160000
DTSTAMP:20260403T124443
CREATED:20230404T173638Z
LAST-MODIFIED:20230508T211204Z
UID:1521-1683727200-1683734400@goodlifesci.sidley.com
SUMMARY:Sidley Digital Health East
DESCRIPTION:Please join us on Wednesday\, May 10 for a digital health-focused roundtable hosted by Sidley and The Digital Therapeutics Alliance. Across two panels\, we will discuss important and timely topics including marketing pathways\, coverage and reimbursement issues\, and more. Get industry tips and key watchouts from a look at the current marketplace. \n \nWhat Does Success Look Like? Overcoming FDA Hurdles and Obtaining Reimbursement\nPanelists will discuss how to successfully bring digital health to market by considering both FDA and post-approval coverage and reimbursement challenges and paths forward. Listen for an update on FDA’s latest guidance and how to make it work for you\, as well as how to navigate benefit categories and reimbursement decisions across payors. \n\nAnnie Saha\, Assistant Director\, Digital Health Center of Excellence\, FDA\nAndy Molnar\, CEO\, Digital Therapeutics Alliance (DTA)\nDeitzah Raby\, General Counsel\, AppliedVR\nEverett Crosland\, Chief Commercial Officer\, Cognito Therapeutics\n\nFireside Chat with Seth Feuerstein\, Founder and CEO of Oui Therapeutics\, and Melissa Reilly\, Chief Growth Officer at Evernorth Behavioral Health\nHear from two experts deeply engaged in digital health. We will hear them share their stories\, discuss launching new digital health therapies\, and speak to expertise that brought them to where they are today. \n\nSeth Feuerstein\, MD\, JD\, Founder and CEO\, Oui Therapeutics and Executive Director and Founder\, Center for Digital Health\, Innovation and Excellence\, Yale School of Medicine\nMelissa Reilly\, Chief Growth Officer\, Evernorth Behavioral Health\n\nFor more information or questions\, please contact globallifesci@sidley.com. \nBoston Life Sciences Roundtable:\nLooking for a deep dive on the current life sciences landscape? Join us for an afternoon of discussions addressing cutting-edge trends at the Boston Life Sciences Roundtable\, on Thursday\, May 11\, following Sidley Digital Health East. Click here for more information and registration. \nThe health of our clients\, colleagues\, and guests is important to us. If you are experiencing cold or flu-like symptoms please stay home and get better. If you are recovering from COVID-19 or have been recently exposed\, please follow applicable guidelines.
URL:https://goodlifesci.sidley.com/event/sidley-digital-health-east/
LOCATION:700 Technology Square\, Cambrige\, MA 02139
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20221201T170000
DTEND;TZID=Europe/Zurich:20221201T200000
DTSTAMP:20260403T124443
CREATED:20221005T175157Z
LAST-MODIFIED:20221103T173736Z
UID:1277-1669914000-1669924800@goodlifesci.sidley.com
SUMMARY:Women’s Life Sciences Network Event – Zürich
DESCRIPTION:Digital Health and Artificial Intelligence: Drivers in Transforming the Life Sciences Industry \nJoin us in Zürich for our next Women’s Life Sciences Network event\, which will feature a panel discussion with leading life sciences industry women about the use of artificial intelligence and digital health. \n \nModerated panel discussion: \n\nData augmenting in healthcare\n\n\nChallenges and opportunities in digital health\n\n\nArtificial intelligence in drug development and beyond\n\nSPEAKERS \nFleur Herrenschmidt\nHead Legal Region Europe Pharma\nNovartis \nLisa Kinsella\nVice President and General Counsel\nModerna \nAfua van Haasteren\nManager\, Health Policy and External Affairs\nRoche Diagnostics \nRSVP HERE \n5:00 – 8:00 p.m. CET\nThe panel discussion will be followed by a networking reception and walking dinner. \nFor more information\, please contact Cristina Menendez Ruiz at +32 2 504 6453 or at cmenendezruiz@sidley.com. \nClick here to join the Women’s Life Sciences Network LinkedIn Group. \nJosefine Sommer\nSenior Managing Associate\, Sidley Austin LLP\nWLSN Co-Founder\njosefine.sommer@sidley.com \nTatjana Sachse\nCounsel\, Sidley Austin LLP\nWLSN Lead\ntsachse@sidley.com \nAnna Pavlou\nHead of Legal\, Global R&D and Regulatory at Galderma\nWLSN Co-Founder\nAnna.Pavlou@galderma.com \n\nIn light of the COVID-19 pandemic\, Sidley is taking precautions to safeguard the well-being of our clients\, colleagues\, and guests. We encourage you to practice social distancing and follow local guidelines. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days\, please refrain from attending this event. We appreciate your cooperation and concern for the health and safety of our guests.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-network-event-zurich/
LOCATION:Kraftwerk\, Selnaustrasse 25\, Zürich\, 8001\, Switzerland
ATTACH;FMTTYPE=image/png:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/10/MN-11337-WLSN-Sidley-865px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221025T133000
DTEND;TZID=America/Los_Angeles:20221025T183000
DTSTAMP:20260403T124443
CREATED:20220922T163821Z
LAST-MODIFIED:20220922T224245Z
UID:1262-1666704600-1666722600@goodlifesci.sidley.com
SUMMARY:Life Sciences Regulatory Bootcamp
DESCRIPTION:Building a foundation for success in the medical products industry\n\nJoin us for an afternoon of discussions designed to provide a foundation in FDA\, healthcare\, and securities issues arising in the development of medical products. Whether you are relatively new to counseling and risk mitigation in these areas or more experienced counsel looking for an efficient way to focus on their application in pre-commercial contexts\, this event is for you. Learn from Sidley’s experienced regulatory and disclosure lawyers and get answers to your most pressing questions. \n \nWho Should Attend: Lawyers needing a practical introduction to legal and regulatory issues arising in the development of medical products. \nFEATURED PANELS \nEssential FDA Concepts and Strategic Considerations for Drug Development \n\nFDA’s expectations of drug developers\nFDA programs to expedite development and regulatory review\nNon-patent exclusivities administered by FDA: considerations for lifecycle management and mitigating litigation risks\nDisputing FDA Actions\n\nProcedural options and definition of success\nKey factors predicting outcomes\nAppropriate means of influencing FDA\n\n\n\nEngagement with Patients and HCPs\, Including Compliance Considerations for Pre-Commercial Products \n\nObtaining coding\, coverage\, and reimbursement\nPricing considerations\nMarket access strategies\, including expanded/post-trial access\nArrangements with HCPs and patients\nRight-sized compliance infrastructure\n\nPractical Approaches to SEC\, Shareholder Litigation\, and FDA Risks in Pre-Approval Communications \n\nSEC and FDA requirements/coordination with respect to pre-approval communications and disclosures for public life science companies\nIssues and trends in shareholder litigation\nPractical approaches to mitigating regulatory\, enforcement\, and litigation risks\n\nRSVP HERE \n1:30 p.m. – 5:30 p.m. PT | Cocktail Reception: 5:30 p.m. – 6:30 p.m. PT \n\nCLE credit for this program is pending. \nFor more information\, contact Sidley Global Life Sciences.
URL:https://goodlifesci.sidley.com/event/life-sciences-regulatory-bootcamp/
LOCATION:Sharon Heights Country Club\, 2900 Sand Hill Rd\, Menlo Park\, CA\, United States
ATTACH;FMTTYPE=image/png:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/09/MN-18777-Life-Sciences-Regulatory-Bootcamp-Web-Graphics_.com-Banner-865-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220922T160000
DTEND;TZID=America/New_York:20220922T180000
DTSTAMP:20260403T124443
CREATED:20220825T230546Z
LAST-MODIFIED:20220826T185216Z
UID:1219-1663862400-1663869600@goodlifesci.sidley.com
SUMMARY:Women’s Life Sciences Network Event – Boston
DESCRIPTION:Join us for our first U.S.-based Women’s Life Sciences Network event in Cambridge\, a center of life sciences and technology. Keynote speaker Lara Sullivan\, President and CEO of Pyxis Oncology\, will share and discuss hot topics in the industry – followed by a networking reception with cocktails and hors d’oeuvres. \n \nClick here to join the Women’s Life Sciences Network LinkedIn Group. \nFor more information\, please contact Sidley Global Life Sciences. \nDonielle McCutcheon\nPartner\, Healthcare\nWLSN Boston Co-Leader\ndmccutcheon@sidley.com \nAdriana V. Tibbitts\nPartner\, Technology and Life Sciences Transactions\nWLSN Boston Co-Leader\natibbitts@sidley.com \nJosefine Sommer\nSenior Managing Associate\, Food\, Drug and Medical Device Regulatory\nWLSN Co-Founder\njosefine.sommer@sidley.com \n\nIn light of the COVID-19 pandemic\, Sidley is taking precautions to safeguard the well-being of our clients\, colleagues\, and guests. If you are experiencing cold or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days\, please refrain from attending this event.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-network-event-boston/
LOCATION:The Royal Sonesta | Studio Patio\, 40 Edwin H Land Blvd\, Cambridge\, MA\, 02142\, United States
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/08/WLSN-Boston1-e1661468822999.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20220906T133000
DTEND;TZID=Europe/Zurich:20220906T170000
DTSTAMP:20260403T124443
CREATED:20220627T182830Z
LAST-MODIFIED:20220629T160431Z
UID:1111-1662471000-1662483600@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2022 and Beyond: Mitigating Risks
DESCRIPTION:Please join Sidley and ISS AG in Bern for an afternoon of practical tips and interactive discussions on current issues\, including: \n\nBridging regulatory gaps across the EU\, UK\, and Switzerland\nManaging risks associated with new developments\n\n \nIndustry speakers\, regulators\, scientific experts\, and counsel will share tips and best practices for the challenges and opportunities that lie ahead for Swiss MedTech enterprises. \nLocation \n\nHotel Schweizerhof | Bahnhofplatz 11 | 3001 Bern \nRegister here \n1:30 p.m. – 5:00 p.m. CET\nCocktail reception to follow \nView agenda here \n\nTopics include: \n\nSustainability\nDigital Health\nCybersecurity\n\nWho should attend? \nExecutives\, investors\, in-house counsel\, and regulatory managers interested and/or facing regulatory issues in Switzerland. \n\nFor more information or questions\, please contact gvaevents@sidley.com. \nIn light of the COVID-19 pandemic\, Sidley is taking precautions to safeguard the well-being of our clients\, colleagues\, and guests. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19\, please refrain from attending this event. \nSidley Austin LLP and ISS AG will process delegate contact details for the purposes of organizing and administering this event and for contacting you about future events. Please note that delegate contact details may be passed between Sidley Austin LLP and ISS AG for the above purposes.
URL:https://goodlifesci.sidley.com/event/medtech-2022-and-beyond-mitigating-risks/
LOCATION:Hotel Schweizerhof\, Bahnhofplatz 11\, Bern\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/06/MN10736LifeSciencesSwitzerlandevent865px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220712T133000
DTEND;TZID=America/New_York:20220712T163000
DTSTAMP:20260403T124443
CREATED:20220614T190519Z
LAST-MODIFIED:20241115T214007Z
UID:1082-1657632600-1657643400@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Please join us for Sidley’s first in-person Boston Life Sciences Roundtable program\, an afternoon of provocative discussions addressing cutting-edge trends and topics. \nTuesday\, July 12\, 2022 \n1:30 p.m. – 4:30 p.m.\nCocktail reception to follow \nFeatured Panels \nLeading Life Sciences Companies: A Conversation with Boston Area General Counsel \nGina Mazzariello\, Chief Legal Officer & General Counsel\, Amylyx Pharmaceuticals\, Inc.\nKaren Tepichin\, General Counsel\, Ginkgo Bioworks\nJoe Vittiglio\, Chief Business and Legal Officer\, Finch Therapeutics\, Inc.\nScott Kaplan\, Partner\, Food\, Drug and Medical Device Regulatory and former FDA Associate Chief Counsel\, Enforcement\nBecky Wood\, Partner\, Food\, Drug and Medical Device Regulatory and former FDA Chief Counsel \nLessons from the Trenches – Navigating FDA\, SEC\, and Strategic Issues in Product Development and Commercialization Messaging \nPamela Connealy\, Chief Financial Officer\, Pyxis Oncology\nHeather Turner\, former Chief Legal Officer\, Lyell Immunopharma\, Inc.\nStephen Cohen\, Partner\, Securities Enforcement and Regulatory\nTorrey Cope\, Partner\, Food\, Drug and Medical Device Regulatory\nFrank Rahmani\, Partner\, Capital Markets \nDown\, But Not Out – Dealing With a Challenging Capital Environment \nChristian Schade\, Chairman and Chief Executive Officer\, Aprea Therapeutics\nGeoff Levin\, Partner\, Private Equity\nAsher Rubin\, Partner\, Technology and Life Sciences Transactions \nKeynote Presentation \nNatalie Silverstein\, M.P.H. \nNatalie Silverstein is an author\, speaker\, consultant and passionate advocate for family and youth service. She is the author of two books about giving back and kindness\, including Simple Acts: The Busy Family’s Guide to Giving Back\, and most recently Simple Acts: The Busy Teen’s Guide to Making A Difference. \nAdditional panelists to be announced. \n\nWHO MAY BE INTERESTED IN ATTENDING \nExecutives\, Investors\, General Counsel\, and Company Counsel \nABOUT THE PROGRAM \nThe Boston Life Sciences Roundtable is an annual event designed to address cutting-edge trends and hot topics in the life sciences sector. Sidley hosts an annual Life Sciences Roundtable in San Francisco and now in Boston. \nFor more information\, contact globallifesci@sidley.com. \nCOVID-19 PROTOCOL \nIn light of the COVID-19 pandemic\, Sidley continues to take precautions to safeguard the health and well-being of our clients\, colleagues\, and guests. Proof of vaccination is required to attend. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days\, we ask that you not attend the event. We appreciate your cooperation and concern for the health and safety of our guests. \nAdditional guidance will be provided prior to the event and in accordance with CDC and local guidelines.
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable/
LOCATION:MassBio\, 700 Technology Square 5th floor\, Cambridge\, MA\, 02139\, United States
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/06/MN14393-Boston-Life-Sciences-Event-Banner-865px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220622T133000
DTEND;TZID=America/Los_Angeles:20220622T163000
DTSTAMP:20260403T124443
CREATED:20220517T154519Z
LAST-MODIFIED:20220621T181704Z
UID:1031-1655904600-1655915400@goodlifesci.sidley.com
SUMMARY:Bay Area Life Sciences Roundtable
DESCRIPTION:Please join Sidley at SFMOMA for the 7th Annual Bay Area Lifesciences Roundtable\, an afternoon of provocative discussions addressing cutting-edge trends and hot topics. \nWe are thrilled to be back together in-person for this year’s event which will be held at a beautiful outdoor space—SFMOMA’s Sculpture Garden. \n \nRSVP \nWednesday\, June 22\, 2022\n1:30 p.m. – 4:30 p.m.\nCocktail reception to follow \nPrivate access to the Fisher Collection and the Contemporary Optics Exhibit will be available during the cocktail reception. \n\nFEATURED PANELS \nAdditional panelists to be announced. \nHot Topics in Managing Global Supply Chain Issues: Before\, During\, and After Launch\nGain valuable insights from in-house and former agency counsel who have been in the trenches. \nTopics will include: \n\nCommon global supply chain patterns for pre-commercial and commercial companies\nHow to manage FDA compliance and quality risks associated with global supply chain\nEvaluating key international reference pricing considerations and trends\nAnalyzing key case study examples\n\nFeatured Panelists \nAngie Lewis-White\, VP Commercial Supply Chain & Contract Manufacturing\, Myovant Sciences \nRaj Pai\, Partner\, Food\, Drug and Medical Device Compliance and Enforcement; formerly with the FDA’s Office of Chief Counsel and former Special Assistant United States Attorney \nCatherine Starks\, Partner\, Healthcare \nAdriana Tibbitts\, Partner\, Technology and Life Sciences Transactions \n  \nOperationalizing Diversity for Positive Business and Clinical Results\nDiversity is a laudable goal\, sufficient in its own right. However\, this panel will take the topic a step further\, exploring concrete ways that diversity can be used to make and run a better life sciences company. \nTopics will include: \n\nExamining diversity in clinical trial design and recruitment to lead to better medicines\nSteps to ensure that market access strategies deliver innovative products to appropriate\, but often underserved\, groups who would benefit\nThe myriad ways that diversity touches how companies operate\, from the board room to the lunch room\n\nFeatured Panelists \nStanley Lewis\, MD\, Founder and CEO of A28 Therapeutics \nBrandon Allgood\, Ph.D.\, Chief Artificial Intelligence Officer\, Valo Health \nR’Kes Starling\, Chief Executive Officer/President\, Reveles Clinical Services \nDeeona Gaskin\, Partner\, Food\, Drug and Medical Device Compliance and Enforcement \nModerators \nStephen Abreu\, Partner\, Technology and Life Sciences Transactions \nMustafa Abdul-Jabbar\, Managing Associate\, Commercial Litigation and Disputes \n  \nManaging Your Message and Positioning: Navigating Strategic and Disclosure Considerations in Product Development and Launch\nDeciding when and how to share non-public information about key events in your company’s life cycle in general and in transactional settings—such as clinical trial results\, regulatory meetings\, and product launch—raises complex questions at the intersection of SEC\, FDA and First Amendment law. Our panel will help you: \n\nUnderstand expectations from key federal regulators\, with insights from seasoned practitioners\, including former FDA Chief Counsel\nTrack evolving First Amendment protections for truthful and non-misleading commercial and scientific speech\nExplore real-world scenarios\, including: preparing for data release from clinical trials\, charting next steps and regulatory pathways\, and evaluating public statements about comparative and competitive positioning\, regulatory meetings\, and feedback\nUnderstand the perspectives of seasoned practitioners and in-house counsel about managing disclosures in transactional settings\, IPOs\, and M&A\n\nFeatured Panelists \nHeather Turner\, former Chief Legal Officer\, Lyell Immunopharma\, Inc. \nFrank Rahmani\, Partner\, Global Life Sciences and Capital Markets \nBecky Wood\, Partner\, Food\, Drug and Medical Device Regulatory and former Chief Counsel\, FDA \n\nCOVID-19 PROTOCOL \nIn light of the COVID-19 pandemic\, Sidley continues to take precautions to safeguard the health and well-being of our clients\, colleagues\, and guests. Proof of vaccination is required to attend. Please follow all CDC and local California guidelines. If you are experiencing cold- or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days\, we ask that you not attend the event. We appreciate your cooperation and concern for the health and safety of our guests. \nAdditional guidance will be provided prior to the event and in accordance with CDC and local guidelines. \n\nWho may be interested in attending \nExecutives\, Investors\, and Company Counsel \nCLE credit for this program is pending. \nFor more information\, contact GlobalLifeSci@sidley.com.
URL:https://goodlifesci.sidley.com/event/bay-area-life-sciences-roundtable/
LOCATION:SFMOMA\, 147 Minna St. Floor 5\, San Francisco\, CA\, 94103\, United States
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/05/MN-10829_LSR-banner-865px-opt.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220622
DTEND;VALUE=DATE:20220624
DTSTAMP:20260403T124443
CREATED:20220608T201642Z
LAST-MODIFIED:20220608T203139Z
UID:1063-1655856000-1656028799@goodlifesci.sidley.com
SUMMARY:Digital Health App'ero and Life Sciences College
DESCRIPTION:Digital Health App’ero \nOn the eve of the Life Sciences College 2022\, we welcome you to our first Digital Health App’ero\, which will feature a panel discussion with key industry representatives on the use of digital health tools by pharma and medtech companies. The panel will be followed by a networking forum for professionals in this space. \nStaying Ahead of the Curve – Issues on the Radar for Pharma and Medical Devices Companies \nPlease join us for our annual life sciences legal conference\, bringing together senior members of the European Commission and industry thought leaders. This edition will focus on a variety of topics\, including the latest regulatory developments in the EU and the outlook for the life sciences industry as a whole. This year’s keynote address will be presented by Andrezj Rys\, Director responsible for Health Systems\, Medical Products and Innovation\, Directorate General for Health and Food Safety (DG Sante)\, European Commission. \nAgenda \nLocation \n\nDigital Health App’ero\nTHE HOTEL – Bd. de Waterloo 38\, 1000 Bruxelles\n6:00 p.m. – 7:30 p.m.\nFollowed by networking drinks \nStaying Ahead of the Curve – Issues on the Radar for Pharma and Medical Devices Companies\nTHE HOTEL – Bd. de Waterloo 38\, 1000 Bruxelles\n8:30 a.m. – 5:10 p.m. followed by networking drinks\nBreakfast will be served from 8:30 a.m. \nRegister here for both events. \n\n\nThe event is open to in-house counsel\, regulators\, and regulatory personnel at pharmaceutical and medical devices companies. There is no registration fee to attend this event. For more information\, please contact Cristina Menéndez Ruiz at +32 2 504 6453 or cmenendezruiz@sidley.com. \nIn light of the COVID-19 pandemic\, Sidley is taking precautions to safeguard the well-being of our clients\, colleagues\, and guests. If you are experiencing cold or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19\, please refrain from attending this event. \n\nKey takeaways from Life Science College 2021 are available here. \nTrendspotting 2022: On the Pulse of Life Sciences
URL:https://goodlifesci.sidley.com/event/digital-health-appero-and-life-sciences-college/
LOCATION:THE HOTEL\, Bd. de Waterloo 38\, 1000 Bruxelles\, Brussels
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/06/MN17888-Digital-Health-Appero-and-Brussels-757-px-banner-002.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220518T080000
DTEND;TZID=America/New_York:20220519T160000
DTSTAMP:20260403T124443
CREATED:20220428T171425Z
LAST-MODIFIED:20220506T200842Z
UID:845-1652860800-1652976000@goodlifesci.sidley.com
SUMMARY:Regulatory Reboot: What You Need to Know About Biopharma Regulation in 2022 and Beyond
DESCRIPTION:Join Sidley for a two-day program designed to provide a sophisticated\, comprehensive foundation in regulatory law for in-house lawyers involved in biopharma development\, manufacturing\, and marketing. Whether you are relatively new to regulatory counseling and risk mitigation or more experienced counsel looking for an efficient way to catch up on developments in the law from the past two years\, this event is for you. By the end of the second day\, you’ll have the information and insights you need to tackle any biopharma regulatory issue and know when to worry\, whom to call\, and how and when to scale up. \n \n\nLearn from Sidley’s most experienced biopharmaceutical regulatory lawyers and head back to work with high-quality substantive materials to make your job easier.\nGet to know your instructors and peers during breaks and over dinner — networking is risk management.\nCome as you are — we will provide the conditions you need for a comfortable\, productive learning experience\, from an on-demand barista to comfortable seating\, great tech\, and high-end supplies.\nIf need be\, catch up on work in our newly refurbished\, sunny\, spacious break-out rooms.\n\nClick here to view the full agenda. \nWednesday\, May 18\, 2022 \nFEATURED SESSIONS \n\nDrug Development — Clinical Trials\, Biostatistics\, Real-World Evidence\, and Disputes\nEthics — Ethics Issues Arising in FDA Regulatory Contexts\nStatutory Exclusivities\nAKS/Fraud & Abuse\n\nThursday\, May 19\, 2022 \nFEATURED SESSIONS \n\nSupply Chain Essentials — DSCSA\, PDMA\, GMP\nPublic Company Disclosure Issues — Regulatory and Enforcement (FDA and SEC)\, Class Actions\nEthics Issues Arising in FDA Regulatory Contexts\n\nWHO SHOULD ATTEND \nIn-house counsel with responsibility for regulatory compliance\, analysis\, engagement\, and risk mitigation. \n\nRegister here \nWednesday\, May 18\n8:00 a.m. – 4:30 p.m.\nReception follows: 4:30 p.m. – 6:30 p.m. \nThursday\, May 19\n8:00 a.m. – 4:00 p.m. \n\nCLE credit for this program is pending. \nFor more information\, contact globallifesci@sidley.com.
URL:https://goodlifesci.sidley.com/event/regulatory-reboot-what-you-need-to-know-about-biopharma-regulation-in-2022-and-beyond/
LOCATION:Sidley’s New York Offices\, 787 Seventh Avenue\, New York\, NY\, 10019\, United States
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/04/MN17430-Regulatory-Reboot-757px-banner100-002.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20220517T180000
DTEND;TZID=Europe/Brussels:20220517T180000
DTSTAMP:20260403T124443
CREATED:20220428T174524Z
LAST-MODIFIED:20241202T200128Z
UID:851-1652810400-1652810400@goodlifesci.sidley.com
SUMMARY:Women’s Life Sciences Network Event: Global Review of Pharmaceutical Regulations
DESCRIPTION:Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. A panel from the International and European pharmaceutical industry associations will share and discuss hot topics in the industry. The panel discussion will include: \n\nGlobal trends on the review of pharmaceutical legislation\nIP rights for innovation and incentives\nMarket access and reimbursement\nRecent antitrust trends\n\nKristine Peers\nGeneral Counsel\nEFPIA \nMelinda Friend\nGeneral Counsel\nIFPMA \n\n\n\n6:00 p.m. CET \nThe panel discussion will be followed by a networking reception and canapés \nSidley Lawyers\nTatjana Sachse | Josefine Sommer \n\nFor more information\, please contact Cristina Menendez Ruiz at +32 2 504 6453 or at cmenendezruiz@sidley.com. \nClick here to join the Women’s Life Sciences Network LinkedIn Group. \nIn light of the COVID-19 pandemic\, Sidley is taking precautions to safeguard the well-being of our clients\, colleagues\, and guests. If you are experiencing cold or flu-like symptoms or if you have been in contact with anyone who has been exposed to or infected with COVID-19 within the past 14 days\, please refrain from attending this event.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-network-event-global-review-of-pharmaceutical-regulations/
LOCATION:Comet\, Place Stephanie 50\, Brussels\, 1050\, Belgium
ATTACH;FMTTYPE=image/png:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/04/MN-9220-WLSN-Sidley-com-865px.png
END:VEVENT
END:VCALENDAR